vs
HeartSciences Inc.（HSCS）与Rani Therapeutics Holdings, Inc.（RANI）财务数据对比。点击上方公司名可切换其他公司
迈瑞尔生命科学是一家总部位于印度古吉拉特邦瓦皮的跨国医疗器械企业，隶属于比拉基亚集团，2006年成立。公司主营血管介入器械、骨科植入物、外科手术器械、耳鼻喉科产品及体外诊断试剂的研发生产，业务覆盖全球150余个国家，截至2024年共有员工1万人。
Rani Therapeutics Holdings是一家临床阶段生物技术企业，专注于开发可替代注射类生物制剂的口服给药方案，核心专利技术RaniPill是一款机器人给药胶囊，可将大分子药物直接递送至肠壁，免除患者注射痛苦，针对糖尿病、自身免疫疾病、骨质疏松等慢性病患者，与多家头部药企合作推进产品管线。
HSCS vs RANI — 直观对比
营收规模更大
HSCS
是对方的Infinity倍
$0
损益表 — Q2 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.4K | $0 |
| 净利润 | $-2.4M | $-5.4M |
| 毛利率 | 58.3% | — |
| 营业利润率 | -85713.2% | — |
| 净利率 | -97179.4% | — |
| 营收同比 | — | — |
| 净利润同比 | -12.9% | 20.2% |
| 每股收益（稀释后） | $-0.85 | $-0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HSCSRANI
| Q4 25 | $2.4K | — | ||
| Q3 25 | $1.9K | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | $0 | $172.0K | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | $14.7K | $0 | ||
| Q4 23 | $3.9K | — |
净利润HSCSRANI
| Q4 25 | $-2.4M | — | ||
| Q3 25 | $-2.1M | $-5.4M | ||
| Q2 25 | — | $-6.7M | ||
| Q1 25 | $-2.5M | $-7.3M | ||
| Q3 24 | — | $-6.8M | ||
| Q2 24 | — | $-6.8M | ||
| Q1 24 | $-1.6M | $-7.5M | ||
| Q4 23 | $-1.7M | — |
毛利率HSCSRANI
| Q4 25 | 58.3% | — | ||
| Q3 25 | 60.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 69.0% | — | ||
| Q4 23 | 61.0% | — |
营业利润率HSCSRANI
| Q4 25 | -85713.2% | — | ||
| Q3 25 | -98637.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -6984.3% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -10376.7% | — | ||
| Q4 23 | -40254.9% | — |
净利率HSCSRANI
| Q4 25 | -97179.4% | — | ||
| Q3 25 | -108157.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -4223.3% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -11182.4% | — | ||
| Q4 23 | -44830.2% | — |
每股收益（稀释后）HSCSRANI
| Q4 25 | $-0.85 | — | ||
| Q3 25 | $-1.58 | $-0.12 | ||
| Q2 25 | — | $-0.18 | ||
| Q1 25 | $-2.57 | $-0.22 | ||
| Q3 24 | — | $-0.24 | ||
| Q2 24 | — | $-0.26 | ||
| Q1 24 | $-3.01 | $-0.29 | ||
| Q4 23 | $-15.92 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.0M | $4.1M |
| 总债务越低越好 | — | $13.8M |
| 股东权益账面价值 | $4.2M | $-7.9M |
| 总资产 | $6.0M | $10.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HSCSRANI
| Q4 25 | $2.0M | — | ||
| Q3 25 | $2.8M | $4.1M | ||
| Q2 25 | — | $10.2M | ||
| Q1 25 | $2.6M | $10.1M | ||
| Q3 24 | — | $4.3M | ||
| Q2 24 | — | $4.5M | ||
| Q1 24 | $7.1M | $6.9M | ||
| Q4 23 | $100.1K | — |
总债务HSCSRANI
| Q4 25 | — | — | ||
| Q3 25 | — | $13.8M | ||
| Q2 25 | — | $17.5M | ||
| Q1 25 | — | $21.3M | ||
| Q3 24 | — | $28.8M | ||
| Q2 24 | — | $30.0M | ||
| Q1 24 | — | $30.0M | ||
| Q4 23 | — | — |
股东权益HSCSRANI
| Q4 25 | $4.2M | — | ||
| Q3 25 | $3.1M | $-7.9M | ||
| Q2 25 | — | $-5.6M | ||
| Q1 25 | $1.8M | $-3.1M | ||
| Q3 24 | — | $3.1M | ||
| Q2 24 | — | $2.8M | ||
| Q1 24 | $8.6M | $7.4M | ||
| Q4 23 | $-1.6M | — |
总资产HSCSRANI
| Q4 25 | $6.0M | — | ||
| Q3 25 | $6.4M | $10.1M | ||
| Q2 25 | — | $16.9M | ||
| Q1 25 | $5.7M | $24.1M | ||
| Q3 24 | — | $43.5M | ||
| Q2 24 | — | $43.7M | ||
| Q1 24 | $10.8M | $53.5M | ||
| Q4 23 | $2.4M | — |
负债/权益比HSCSRANI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 9.21× | ||
| Q2 24 | — | 10.58× | ||
| Q1 24 | — | 4.06× | ||
| Q4 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.3M | $-5.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流HSCSRANI
| Q4 25 | $-2.3M | — | ||
| Q3 25 | $-2.0M | $-5.1M | ||
| Q2 25 | — | $-5.8M | ||
| Q1 25 | $-1.6M | $-8.1M | ||
| Q3 24 | — | $-8.4M | ||
| Q2 24 | — | $-9.0M | ||
| Q1 24 | $-2.1M | $-9.4M | ||
| Q4 23 | $-988.2K | — |
自由现金流HSCSRANI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-5.8M | ||
| Q1 25 | — | $-8.2M | ||
| Q3 24 | — | $-8.5M | ||
| Q2 24 | — | $-9.1M | ||
| Q1 24 | $-2.1M | $-9.4M | ||
| Q4 23 | $-990.1K | — |
自由现金流率HSCSRANI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -4767.4% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -14352.1% | — | ||
| Q4 23 | -25388.2% | — |
资本支出强度HSCSRANI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 29.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 59.8% | — | ||
| Q4 23 | 50.1% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
